Intention-to-treat population
|
8,010
|
Eighteen randomly assigned patients withdrew consent to participate before starting treatment.
|
Two-arm randomization option
|
1,828
| |
Four-arm randomization option
|
6,182
| |
Primary core analysis population
|
8,010
|
Follow-up for two sequential treatment groups is censored at 2 years (time of treatment switch).
|
Monotherapy population
|
4,922
|
Patients who were randomly assigned to receive 5 years of tamoxifen alone or letrozole alone.
|
Two-arm randomization option
|
1,828
| |
Four-arm randomization option
|
3,094
| |
Sequential treatment analysis population
|
6,182
|
Patients in the intention-to-treat population enrolled in the four-arm randomization option.
|